Postauthorization safety surveillance of ADVATE [antihaemophilic factor (recombinant), plasma/albumin-free method] demonstrates efficacy, safety and low-risk for immunogenicity in routine clinical practice.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples